-
Symbol
-
ANTX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.00001 per share
-
Latest Disclosed Shares Owned
-
927,201 shares
-
Security Ownership %
-
3.1%
Brii Biosciences Limited ownership in AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)
14 Feb 2025 - Brii Biosciences Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 927,201 shares of AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX).
This represents 3.1% ownership of the company.
This is the first filing by Brii Biosciences Ltd disclosing ownership of AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX).